First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
Horn, Leora, Mansfield, Aaron S, Szczęsna, Aleksandra, Havel, Libor, Krzakowski, Maciej, Hochmair, Maximilian J, Huemer, Florian, Losonczy, György, Johnson, Melissa L, Nishio, Makoto, Reck, Martin, Mok, Tony, Lam, Sivuonthanh, Shames, David S, Liu, Juan, Ding, Beiying, Lopez-Chavez, Ariel, Kabbinavar, Fairooz, Lin, Wei, Sandler, Alan, Liu, Stephen V
Published in The New England journal of medicine (06.12.2018)
Published in The New England journal of medicine (06.12.2018)
Get full text
Journal Article
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
Patil, Namrata S., Nabet, Barzin Y., Müller, Sören, Koeppen, Hartmut, Zou, Wei, Giltnane, Jennifer, Au-Yeung, Amelia, Srivats, Shyam, Cheng, Jason H., Takahashi, Chikara, de Almeida, Patricia E., Chitre, Avantika S., Grogan, Jane L., Rangell, Linda, Jayakar, Sangeeta, Peterson, Maureen, Hsia, Allison W., O’Gorman, William E., Ballinger, Marcus, Banchereau, Romain, Shames, David S.
Published in Cancer cell (14.03.2022)
Published in Cancer cell (14.03.2022)
Get full text
Journal Article
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
Powles, Thomas, Assaf, Zoe June, Davarpanah, Nicole, Banchereau, Romain, Szabados, Bernadett E., Yuen, Kobe C., Grivas, Petros, Hussain, Maha, Oudard, Stephane, Gschwend, Jürgen E., Albers, Peter, Castellano, Daniel, Nishiyama, Hiroyuki, Daneshmand, Siamak, Sharma, Shruti, Zimmermann, Bernhard G., Sethi, Himanshu, Aleshin, Alexey, Perdicchio, Maurizio, Zhang, Jingbin, Shames, David S., Degaonkar, Viraj, Shen, Xiaodong, Carter, Corey, Bais, Carlos, Bellmunt, Joaquim, Mariathasan, Sanjeev
Published in Nature (London) (15.07.2021)
Published in Nature (London) (15.07.2021)
Get full text
Journal Article
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
Gandara, David R., Paul, Sarah M., Kowanetz, Marcin, Schleifman, Erica, Zou, Wei, Li, Yan, Rittmeyer, Achim, Fehrenbacher, Louis, Otto, Geoff, Malboeuf, Christine, Lieber, Daniel S., Lipson, Doron, Silterra, Jacob, Amler, Lukas, Riehl, Todd, Cummings, Craig A., Hegde, Priti S., Sandler, Alan, Ballinger, Marcus, Fabrizio, David, Mok, Tony, Shames, David S.
Published in Nature medicine (01.09.2018)
Published in Nature medicine (01.09.2018)
Get full text
Journal Article
Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLung
Spigel, David R, Edelman, Martin J, O'Byrne, Kenneth, Paz-Ares, Luis, Mocci, Simonetta, Phan, See, Shames, David S, Smith, Dustin, Yu, Wei, Paton, Virginia E, Mok, Tony
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers
Goldstein, Leonard D., Lee, James, Gnad, Florian, Klijn, Christiaan, Schaub, Annalisa, Reeder, Jens, Daemen, Anneleen, Bakalarski, Corey E., Holcomb, Thomas, Shames, David S., Hartmaier, Ryan J., Chmielecki, Juliann, Seshagiri, Somasekar, Gentleman, Robert, Stokoe, David
Published in Cell reports (Cambridge) (06.09.2016)
Published in Cell reports (Cambridge) (06.09.2016)
Get full text
Journal Article
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Gay, Carl M., Stewart, C. Allison, Park, Elizabeth M., Diao, Lixia, Groves, Sarah M., Heeke, Simon, Nabet, Barzin Y., Fujimoto, Junya, Solis, Luisa M., Lu, Wei, Xi, Yuanxin, Cardnell, Robert J., Wang, Qi, Fabbri, Giulia, Cargill, Kasey R., Vokes, Natalie I., Ramkumar, Kavya, Zhang, Bingnan, Della Corte, Carminia M., Robson, Paul, Swisher, Stephen G., Roth, Jack A., Glisson, Bonnie S., Shames, David S., Wistuba, Ignacio I., Wang, Jing, Quaranta, Vito, Minna, John, Heymach, John V., Byers, Lauren Averett
Published in Cancer cell (08.03.2021)
Published in Cancer cell (08.03.2021)
Get full text
Journal Article
Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy
Mok, Tony, Wu, Yi-Long, Lee, Jin Soo, Yu, Chong-Jen, Sriuranpong, Virote, Sandoval-Tan, Jennifer, Ladrera, Guia, Thongprasert, Sumitra, Srimuninnimit, Vichien, Liao, Meilin, Zhu, Yunzhong, Zhou, Caicun, Fuerte, Fatima, Margono, Benjamin, Wen, Wei, Tsai, Julie, Truman, Matt, Klughammer, Barbara, Shames, David S, Wu, Lin
Published in Clinical cancer research (15.07.2015)
Published in Clinical cancer research (15.07.2015)
Get full text
Journal Article
Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells
Chen, Pei-Hsuan, Cai, Ling, Huffman, Kenneth, Yang, Chendong, Kim, Jiyeon, Faubert, Brandon, Boroughs, Lindsey, Ko, Bookyung, Sudderth, Jessica, McMillan, Elizabeth A., Girard, Luc, Chen, Dong, Peyton, Michael, Shields, Misty D., Yao, Bo, Shames, David S., Kim, Hyun Seok, Timmons, Brenda, Sekine, Ikuo, Britt, Rebecca, Weber, Stephanie, Byers, Lauren A., Heymach, John V., Chen, Jing, White, Michael A., Minna, John D., Xiao, Guanghua, DeBerardinis, Ralph J.
Published in Molecular cell (05.12.2019)
Published in Molecular cell (05.12.2019)
Get full text
Journal Article
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
Rudin, Charles M, Durinck, Steffen, Stawiski, Eric W, Poirier, John T, Modrusan, Zora, Shames, David S, Bergbower, Emily A, Guan, Yinghui, Shin, James, Guillory, Joseph, Rivers, Celina Sanchez, Foo, Catherine K, Bhatt, Deepali, Stinson, Jeremy, Gnad, Florian, Haverty, Peter M, Gentleman, Robert, Chaudhuri, Subhra, Janakiraman, Vasantharajan, Jaiswal, Bijay S, Parikh, Chaitali, Yuan, Wenlin, Zhang, Zemin, Koeppen, Hartmut, Wu, Thomas D, Stern, Howard M, Yauch, Robert L, Huffman, Kenneth E, Paskulin, Diego D, Illei, Peter B, Varella-Garcia, Marileila, Gazdar, Adi F, de Sauvage, Frederic J, Bourgon, Richard, Minna, John D, Brock, Malcolm V, Seshagiri, Somasekar
Published in Nature genetics (01.10.2012)
Published in Nature genetics (01.10.2012)
Get full text
Journal Article
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Chaft, Jamie E., Oezkan, Filiz, Kris, Mark G., Bunn, Paul A., Wistuba, Ignacio I., Kwiatkowski, David J., Owen, Dwight H., Tang, Yan, Johnson, Bruce E., Lee, Jay M., Lozanski, Gerard, Pietrzak, Maciej, Seweryn, Michal, Byun, Woo Yul, Schulze, Katja, Nicholas, Alan, Johnson, Ann, Grindheim, Jessica, Hilz, Stephanie, Shames, David S., Rivard, Chris, Toloza, Eric, Haura, Eric B., McNamee, Ciaran J., Patterson, G. Alexander, Waqar, Saiama N., Rusch, Valerie W., Carbone, David P.
Published in Nature medicine (01.10.2022)
Published in Nature medicine (01.10.2022)
Get full text
Journal Article
Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells
Soh, Junichi, Okumura, Naoki, Lockwood, William W, Yamamoto, Hiromasa, Shigematsu, Hisayuki, Zhang, Wei, Chari, Raj, Shames, David S, Tang, Ximing, MacAulay, Calum, Varella-Garcia, Marileila, Vooder, Tõnu, Wistuba, Ignacio I, Lam, Stephen, Brekken, Rolf, Toyooka, Shinichi, Minna, John D, Lam, Wan L, Gazdar, Adi F
Published in PloS one (14.10.2009)
Published in PloS one (14.10.2009)
Get full text
Journal Article
Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)
Kowanetz, Marcin, Zou, Wei, Gettinger, Scott N., Koeppen, Hartmut, Kockx, Mark, Schmid, Peter, Kadel, Edward E., Wistuba, Ignacio, Chaft, Jamie, Rizvi, Naiyer A., Spigel, David R., Spira, Alexander, Hirsch, Fred R., Cohen, Victor, Smith, Dustin, Boyd, Zach, Miley, Natasha, Flynn, Susan, Leveque, Vincent, Shames, David S., Ballinger, Marcus, Mocci, Simonetta, Shankar, Geetha, Funke, Roel, Hampton, Garret, Sandler, Alan, Amler, Lukas, Mellman, Ira, Chen, Daniel S., Hegde, Priti S.
Published in Proceedings of the National Academy of Sciences - PNAS (23.10.2018)
Published in Proceedings of the National Academy of Sciences - PNAS (23.10.2018)
Get full text
Journal Article
Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial
Kim, Edward S., Velcheti, Vamsidhar, Mekhail, Tarek, Yun, Cindy, Shagan, Sarah M., Hu, Sylvia, Chae, Young Kwang, Leal, Ticiana A., Dowell, Jonathan E., Tsai, Michaela L., Dakhil, Christopher S. R., Stella, Philip, Jin, Yanling, Shames, David S., Schleifman, Erica, Fabrizio, David A., Phan, See, Socinski, Mark A.
Published in Nature medicine (01.05.2022)
Published in Nature medicine (01.05.2022)
Get full text
Journal Article
Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma: The METGastric Randomized Clinical Trial
Shah, Manish A, Bang, Yung-Jue, Lordick, Florian, Alsina, Maria, Chen, Meng, Hack, Stephen P, Bruey, Jean Marie, Smith, Dustin, McCaffery, Ian, Shames, David S, Phan, See, Cunningham, David
Published in JAMA oncology (01.05.2017)
Published in JAMA oncology (01.05.2017)
Get more information
Journal Article
Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial
Peters, Solange, Dziadziuszko, Rafal, Morabito, Alessandro, Felip, Enriqueta, Gadgeel, Shirish M., Cheema, Parneet, Cobo, Manuel, Andric, Zoran, Barrios, Carlos H., Yamaguchi, Masafumi, Dansin, Eric, Danchaivijitr, Pongwut, Johnson, Melissa, Novello, Silvia, Mathisen, Michael S., Shagan, Sarah M., Schleifman, Erica, Wang, Jin, Yan, Mark, Mocci, Simonetta, Voong, David, Fabrizio, David A., Shames, David S., Riehl, Todd, Gandara, David R., Mok, Tony
Published in Nature medicine (01.09.2022)
Published in Nature medicine (01.09.2022)
Get full text
Journal Article
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
Nabet, Barzin Y., Hamidi, Habib, Lee, Myung Chang, Banchereau, Romain, Morris, Stefanie, Adler, Leah, Gayevskiy, Velimir, Elhossiny, Ahmed M., Srivastava, Minu K., Patil, Namrata S., Smith, Kiandra A., Jesudason, Rajiv, Chan, Caleb, Chang, Patrick S., Fernandez, Matthew, Rost, Sandra, McGinnis, Lisa M., Koeppen, Hartmut, Gay, Carl M., Minna, John D., Heymach, John V., Chan, Joseph M., Rudin, Charles M., Byers, Lauren A., Liu, Stephen V., Reck, Martin, Shames, David S.
Published in Cancer cell (11.03.2024)
Published in Cancer cell (11.03.2024)
Get full text
Journal Article
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial
Rosell, Rafael, Dafni, Urania, Felip, Enriqueta, Curioni-Fontecedro, Alessandra, Gautschi, Oliver, Peters, Solange, Massutí, Bartomeu, Palmero, Ramon, Aix, Santiago Ponce, Carcereny, Enric, Früh, Martin, Pless, Miklos, Popat, Sanjay, Kotsakis, Athanasios, Cuffe, Sinead, Bidoli, Paolo, Favaretto, Adolfo, Froesch, Patrizia, Reguart, Noemí, Puente, Javier, Coate, Linda, Barlesi, Fabrice, Rauch, Daniel, Thomas, Michael, Camps, Carlos, Gómez-Codina, Jose, Majem, Margarita, Porta, Rut, Shah, Riyaz, Hanrahan, Emer, Kammler, Roswitha, Ruepp, Barbara, Rabaglio, Manuela, Kassapian, Marie, Karachaliou, Niki, Tam, Rachel, Shames, David S, Molina-Vila, Miguel A, Stahel, Rolf A
Published in The lancet respiratory medicine (01.05.2017)
Published in The lancet respiratory medicine (01.05.2017)
Get more information
Journal Article